+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluindione"

Fluindione (CAS 957-56-2) Global Market Research Report 2024 - Product Thumbnail Image

Fluindione (CAS 957-56-2) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
2020 Fluindione Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Fluindione Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2020
  • Japan, United States, ... Japan, United States, Europe
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Fluindione is a hematological drug used to treat and prevent thromboembolic disorders, such as deep vein thrombosis and pulmonary embolism. It is a vitamin K antagonist, meaning it works by blocking the action of vitamin K in the body, which is necessary for the formation of blood clots. Fluindione is available in both oral and injectable forms, and is often used in combination with other anticoagulants. It is also used to treat atrial fibrillation, a type of irregular heartbeat. The Fluindione market is highly competitive, with a number of major pharmaceutical companies offering their own versions of the drug. These include Bayer, Pfizer, Sanofi, and Bristol-Myers Squibb. Generic versions of the drug are also available, produced by a variety of generic drug manufacturers. Show Less Read more